Top news of the week: 07.04.2023.
The ‘new, old kids’ on the biotech block unveil a $350M stealth science fund. And they’re going very, very early
Richard Lim and his two co-founders at Cure Ventures have some biotech stories to tell. Lim recalls the time some 17 years ago he and Lou Tartaglia were going to start something — but then ...
Sensible Biotechnologies Partners with Ginkgo to Develop Novel mRNA Manufacturing Platform
mRNA technology has the potential to help develop many life-saving therapeutics and vaccines.
BIO-Europe Spring 2023: The Highlights
As BIO Europe Spring took place from March 20 to 22, here are some of the key take-home reports from the event.
Cure Ventures Launches with $350M to De-Risk Innovation
With an inaugural $350 million fund, Cure Ventures launched Tuesday to support early-stage companies with cutting-edge curative technologies and help them de-risk their science
A mini-heart in a Petri dish
A team of scientists at TUM has induced stem cells to emulate the development of the human heart. The result is a sort of “mini-heart” known as an organoid.
Drug Development For Neglected Tropical Diseases Is Finally Getting A Tool That Can Get The Job Done
The neglected tropical diseases impact millions of the world’s poorest each year. Now researchers in Africa can advance their drug discovery efforts through Collaborative Drug Discovery.
HuidaGene Receives Orphan Drug Designation for Gene Therapy of Blindness
HuidaGene Receives Orphan Drug Designation for Gene Therapy of Blindness - read this article along with other careers information, tips and advice on BioSpace
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
-EU and UK filings completed in 2022; submissions validated by EMA and MHRA and the review procedure has begun as of January 2023 - BOSTON & ZUG, Switzerland --(BUSINESS WIRE)--Apr. 3, ...